title: Inhibition of matrix metalloproteinase activity prevents increases in myocardial tumor necrosis factor-alpha.
abstract: TNF-alpha is known to cause adverse myocardial remodeling. While we have previously shown a role for cardiac mast cells in mediating increases in myocardial TNF-alpha, however, matrix metalloproteinase (MMP) activation of TNF-alpha may also be contributory. We sought to determine the relative roles of MMPs and cardiac mast cells in the activation of TNF-alpha in the hearts of rats subjected to chronic volume overload. Interventions with the broad spectrum MMP inhibitor, GM6001, or the mast cell stabilizer, nedocromil, were performed in the rat aortocaval fistula (ACF) model of volume overload. Myocardial TNF-alpha levels were significantly increased in the ACF. This increase was prevented by MMP inhibition with GM6001 (p< or =0.001 vs. ACF). Conversely, myocardial TNF-alpha levels were increased in the ACF+nedocromil treated fistula groups (p< or =0.001 vs. sham). The degradation of interstitial collagen volume fraction seen in the untreated ACF group was prevented in both the GM6001 and nedocromil treated hearts. Significant increases in LV myocardial ET-1 levels also occurred in the ACF group at 3days post-fistula. Whereas administration of GM6001 significantly attenuated this increase, mast cell stabilization with nedocromil markedly exacerbated the increase, producing ET-1 levels 6.5 fold and 2 fold greater than that in the sham-operated control and ACF group, respectively. The efficacy of the MMP inhibitor, GM6001, to prevent increased levels of myocardial TNF-alpha is indicative of MMP-mediated cleavage of latent extracellular membrane-bound TNF-alpha protein as the primary source of bioactive TNF-alpha in the myocardium of the volume overload heart.
authors.affiliation: Department of Pharmacology, University of Mississippi School of Pharmacy, University, MS 38677, USA. dmurray@olemiss.edu
authors.forename: David B
authors.initials: DB
authors.lastname: Murray
authors.forename: Scott P
authors.initials: SP
authors.lastname: Levick
authors.forename: Gregory L
authors.initials: GL
authors.lastname: Brower
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Janicki
mesh_terms: D000818:Animals; D002452:Cell Count; D015550:Cell Degranulation; D016207:Cytokines / Q000378:metabolism; D005109:Extracellular Matrix / Q000378:metabolism; D008297:Male; D008407:Mast Cells / Q000166:cytology / Q000502:physiology; D061965:Matrix Metalloproteinase Inhibitors; D020782:Matrix Metalloproteinases / Q000378:metabolism; D009206:Myocardium / Q000201:enzymology*; D018377:Neurotransmitter Agents / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D016207:Cytokines; D061965:Matrix Metalloproteinase Inhibitors; D018377:Neurotransmitter Agents; D014409:Tumor Necrosis Factor-alpha; D020782:Matrix Metalloproteinases
references.citation: Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1251-7
references.pmid: 18178727
references.citation: Nature. 1997 Feb 20;385(6618):729-33
references.pmid: 9034190
references.citation: Nature. 1997 Feb 20;385(6618):733-6
references.pmid: 9034191
references.citation: Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2152-8
references.pmid: 12003823
references.citation: Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H109-16
references.pmid: 19429817
references.citation: Eur J Immunol. 2004 Jul;34(7):1910-9
references.pmid: 15214039
references.citation: Anal Biochem. 2007 Jul 15;366(2):144-8
references.pmid: 17548045
references.citation: J Leukoc Biol. 2002 May;71(5):829-36
references.pmid: 11994508
references.citation: Basic Res Cardiol. 2008 Sep;103(5):485-92
references.pmid: 18651091
references.citation: Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):268-73
references.pmid: 11834527
references.citation: Am J Physiol Heart Circ Physiol. 2009 Oct;297(4):H1462-8
references.pmid: 19666842
references.citation: Eur J Heart Fail. 2008 Feb;10(2):125-8
references.pmid: 18234554
references.citation: J Mol Cell Cardiol. 2010 Jul;49(1):70-8
references.pmid: 20045005
references.citation: Circ Res. 2002 Apr 19;90(7):807-13
references.pmid: 11964374
references.citation: Circulation. 1998 Aug 18;98(7):699-710
references.pmid: 9715863
references.citation: Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H984-91
references.pmid: 11179039
references.citation: J Clin Invest. 1995 Aug;96(2):1042-52
references.pmid: 7635940
references.citation: Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1216-22
references.pmid: 17434981
references.citation: Pharmacol Rep. 2008 Jul-Aug;60(4):524-31
references.pmid: 18799821
references.citation: J Med Chem. 1998 Jan 15;41(2):199-223
references.pmid: 9457244
references.citation: Circ Res. 2007 Jan 5;100(1):140-6
references.pmid: 17170366
references.citation: Am J Physiol. 1998 Mar;274(3):R577-95
references.pmid: 9530222
references.citation: Toxicology. 2006 Feb 15;219(1-3):142-9
references.pmid: 16406210
references.citation: Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H875-83
references.pmid: 18065523
references.citation: Basic Res Cardiol. 2007 Jan;102(1):63-72
references.pmid: 16817025
references.citation: Nature. 2004 Nov 25;432(7016):512-6
references.pmid: 15543132
references.citation: Basic Res Cardiol. 2010 Mar;105(2):301-13
references.pmid: 19629561
references.citation: Cardiovasc Res. 2003 Dec 1;60(3):608-16
references.pmid: 14659806
references.citation: Biochemistry. 2004 Jun 15;43(23):7227-35
references.pmid: 15182168
references.citation: Histochem J. 1999 Apr;31(4):221-9
references.pmid: 10447063
references.citation: Circulation. 2004 Jan 20;109(2):262-8
references.pmid: 14699008
references.citation: Basic Res Cardiol. 2010 Jan;105(1):139-50
references.pmid: 19823892
references.citation: J Leukoc Biol. 1995 May;57(5):774-7
references.pmid: 7759957
references.citation: Scand J Gastroenterol. 2006 Nov;41(11):1320-9
references.pmid: 17060126
references.citation: J Mol Cell Cardiol. 2002 Jan;34(1):51-62
references.pmid: 11812164
references.citation: Eur J Biochem. 1997 Dec 15;250(3):751-7
references.pmid: 9461298
references.citation: Am J Physiol Heart Circ Physiol. 2004 Nov;287(5):H2295-9
references.pmid: 15231495
references.citation: Circulation. 1998 Apr 14;97(14):1382-91
references.pmid: 9577950
references.citation: Inflamm Res. 2008 May;57(5):241-6
references.pmid: 18465084
references.citation: J Mol Cell Cardiol. 2007 Jan;42(1):133-41
references.pmid: 17101148
references.citation: J Mol Cell Cardiol. 2008 Jul;45(1):56-61
references.pmid: 18538342
references.citation: J Card Fail. 2005 Sep;11(7):548-56
references.pmid: 16198252
references.citation: Am J Physiol Cell Physiol. 2007 Oct;293(4):C1362-73
references.pmid: 17670887
references.citation: Basic Res Cardiol. 2010 Mar;105(2):219-26
references.pmid: 19859778
references.citation: Circ Res. 1999 Nov 12;85(10):906-11
references.pmid: 10559137
references.citation: Am J Physiol Heart Circ Physiol. 2002 Aug;283(2):H518-25
references.pmid: 12124196
references.citation: Basic Res Cardiol. 2008 Sep;103(5):493-500
references.pmid: 18600363
references.citation: Exp Cell Res. 2004 Oct 1;299(2):465-75
references.pmid: 15350544
references.citation: Am J Physiol Heart Circ Physiol. 2000 Aug;279(2):H601-9
references.pmid: 10924059
references.citation: Circulation. 2001 Feb 27;103(8):1044-7
references.pmid: 11222463